{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:08:05Z","timestamp":1773972485817,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,7]]},"DOI":"10.1093\/infdis\/jiy410","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T01:52:35Z","timestamp":1530928355000},"page":"177-185","source":"Crossref","is-referenced-by-count":21,"title":["Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study"],"prefix":"10.1093","volume":"219","author":[{"given":"Jeysen","family":"Yogaratnam","sequence":"first","affiliation":[{"name":"Alios Biopharma, part of Janssen Pharmaceutical Companies, South San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Rito","sequence":"additional","affiliation":[{"name":"Alios Biopharma, part of Janssen Pharmaceutical Companies, South San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas N","family":"Kakuda","sequence":"additional","affiliation":[{"name":"Alios Biopharma, part of Janssen Pharmaceutical Companies, South San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein","family":"Fennema","sequence":"additional","affiliation":[{"name":"Janssen Research and Development, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kusum","family":"Gupta","sequence":"additional","affiliation":[{"name":"Alios Biopharma, part of Janssen Pharmaceutical Companies, South San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Andreas","family":"Jekle","sequence":"additional","affiliation":[{"name":"Alios Biopharma, part of Janssen Pharmaceutical Companies, South San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Hammersmith Medicines Research, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Boyce","sequence":"additional","affiliation":[{"name":"Hammersmith Medicines Research, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omair","family":"Sahgal","sequence":"additional","affiliation":[{"name":"Hammersmith Medicines Research, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh","family":"Balaratnam","sequence":"additional","affiliation":[{"name":"hVIVO Services, Queen Mary BioEnterprises Innovation Centre, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushmita","family":"Chanda","sequence":"additional","affiliation":[{"name":"Alios Biopharma, part of Janssen Pharmaceutical Companies, South San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Van Remoortere","sequence":"additional","affiliation":[{"name":"Janssen Research and Development, Titusville, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian A","family":"Symons","sequence":"additional","affiliation":[{"name":"Alios Biopharma, part of Janssen Pharmaceutical Companies, South San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Fry","sequence":"additional","affiliation":[{"name":"Alios Biopharma, part of Janssen Pharmaceutical Companies, South San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"key\n\t\t\t\t2018122606584285000_CIT0001","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","article-title":"Influenza","volume":"390","author":"Paules","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0002","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0003","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S1473-3099(14)70821-7","article-title":"International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). Antiviral combinations for severe influenza","volume":"14","author":"Dunning","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0004","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children","volume":"1","author":"Jefferson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0005","doi-asserted-by":"crossref","first-page":"g2547","DOI":"10.1136\/bmj.g2547","article-title":"Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments","volume":"348","author":"Heneghan","year":"2014","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0006","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current and next generation influenza vaccines: formulation and production strategies","volume":"94","author":"Soema","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1874306401509010009","article-title":"The impact of vaccination on influenza-related respiratory failure and mortality in hospitalized elderly patients over the 2013\u20132014 season","volume":"23","author":"Joshi","year":"2015","journal-title":"Open Respir Med J"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0008","volume-title":"Preclinical antiviral activity and ADME characteristics of AL-794, a novel influenza endonuclease inhibitor (Late Breaker Oral presentation). Options IX meeting. Annual scientific conference for international society for influenza and respiratory and viral disease, Chicago, 28 August","author":"Jekle","year":"2016"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0009","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijid.2016.05.013","article-title":"Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies","volume":"49","author":"Balasingam","year":"2016","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1473-3099(15)00068-7","article-title":"Design, recruitment, and microbiological considerations in human challenge studies","volume":"15","author":"Darton","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0011"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0012","doi-asserted-by":"crossref","first-page":"e0145902","DOI":"10.1371\/journal.pone.0145902","article-title":"Accelerating influenza research: vaccines, antivirals, immunomodulators and monoclonal antibodies. The manufacture of a new wild-type H3N2 virus for the human viral challenge model","volume":"11","author":"Fullen","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0013","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1111\/j.1750-2659.2011.00287.x","article-title":"Liver involvement during influenza infection: perspective on the 2009 influenza pandemic","volume":"6","author":"Papic","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0014","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0264-410X(99)00334-5","article-title":"Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses","volume":"18","author":"Treanor","year":"1999","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0015","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2105\/AJPH.87.12.1944","article-title":"The impact of influenza epidemics on mortality: introducing a severity index","volume":"87","author":"Simonsen","year":"1997","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0016","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018122606584285000_CIT0017","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/aje\/kwm375","article-title":"Time lines of infection and disease in human influenza: a review of volunteer challenge studies","volume":"167","author":"Carrat","year":"2008","journal-title":"Am J Epidemiol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/2\/177\/27276211\/jiy410.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T08:57:14Z","timestamp":1571561834000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/2\/177\/5060129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,7,26]]},"published-print":{"date-parts":[[2019,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy410","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1,15]]},"published":{"date-parts":[[2018,7,26]]}}}